BR9711692A - Regulated steel promoter - Google Patents
Regulated steel promoterInfo
- Publication number
- BR9711692A BR9711692A BR9711692-0A BR9711692A BR9711692A BR 9711692 A BR9711692 A BR 9711692A BR 9711692 A BR9711692 A BR 9711692A BR 9711692 A BR9711692 A BR 9711692A
- Authority
- BR
- Brazil
- Prior art keywords
- promoter
- regulated
- iron
- regulated steel
- sequence
- Prior art date
Links
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- 229910000831 Steel Inorganic materials 0.000 title 1
- 239000010959 steel Substances 0.000 title 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
<B>PROMOTOR REGULADO POR FERRO E USOS DO MESMO<D> A presente invenção fornece um promotor regulado por ferro. O promotor compreende a seq³ência de DNA (Figura 1), ou um fragmento da mesma que inclui a seq³ência dos resíduos 284 a 409, ou uma seq³ência de ácido nucleico funcionalmente equivalente. São também fornecidos vetores e células hospedeiras recombinantes incluindo o promotor e composições para uso na indução de uma resposta imune em um animal.<B> IRON-REGULATED PROMOTER AND USES OF THE SAME <D> The present invention provides an iron-regulated promoter. The promoter comprises the DNA sequence (Figure 1), or a fragment thereof that includes the sequence of residues 284 to 409, or a functionally equivalent nucleic acid sequence. Recombinant host vectors and cells including the promoter and compositions for use in inducing an immune response in an animal are also provided.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO2164A AUPO216496A0 (en) | 1996-09-06 | 1996-09-06 | Inducible promoters |
AUPO2454A AUPO245496A0 (en) | 1996-09-19 | 1996-09-19 | Site-specific chromosomal integration system |
AUPO7801A AUPO780197A0 (en) | 1997-07-09 | 1997-07-09 | Site-specific chromosomal integration system incorporating inducible promoter |
PCT/AU1997/000503 WO1998010064A1 (en) | 1996-09-06 | 1997-08-08 | Iron regulated promoter and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9711692A true BR9711692A (en) | 2000-10-24 |
Family
ID=27157946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9711692-0A BR9711692A (en) | 1996-09-06 | 1997-08-08 | Regulated steel promoter |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0964924A4 (en) |
AR (1) | AR008171A1 (en) |
BR (1) | BR9711692A (en) |
CA (1) | CA2265883A1 (en) |
NZ (1) | NZ334649A (en) |
UY (1) | UY24698A1 (en) |
WO (1) | WO1998010064A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE190660T1 (en) * | 1990-12-18 | 2000-04-15 | Gen Hospital Corp | IMPROVED VACCINES |
WO1994019482A1 (en) * | 1993-02-22 | 1994-09-01 | The General Hospital Corporation | Heterologous antigens in live cell vaccine strains |
-
1997
- 1997-08-08 BR BR9711692-0A patent/BR9711692A/en unknown
- 1997-08-08 NZ NZ334649A patent/NZ334649A/en unknown
- 1997-08-08 CA CA002265883A patent/CA2265883A1/en not_active Abandoned
- 1997-08-08 EP EP97933590A patent/EP0964924A4/en not_active Withdrawn
- 1997-08-08 WO PCT/AU1997/000503 patent/WO1998010064A1/en not_active Application Discontinuation
- 1997-09-05 UY UY24698A patent/UY24698A1/en not_active Application Discontinuation
- 1997-09-08 AR ARP970104095A patent/AR008171A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY24698A1 (en) | 1998-02-12 |
CA2265883A1 (en) | 1998-03-12 |
WO1998010064A1 (en) | 1998-03-12 |
EP0964924A4 (en) | 2001-04-18 |
NZ334649A (en) | 2000-08-25 |
AR008171A1 (en) | 1999-12-09 |
EP0964924A1 (en) | 1999-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95115239A (en) | Erythropoietin analog | |
BR9809445A (en) | Polypeptide comprising an immunogenic portion of a m antigen. tubercolosis, dna molecule, expression vector, host cell, pharmaceutical composition, vaccine, fusion protein, processes for inducing protective immunity in a patient, tuberculosis detection process in a patient, and, diagnostic kit. | |
ES2070866T3 (en) | RECOMBINANT VACCINES AGAINST COCCIDIOSIS. | |
ES2150496T3 (en) | CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS. | |
NO952744D0 (en) | Cytokine-limiting agents | |
FI943512A (en) | Human serum albumin, preparation and use | |
DK1025236T3 (en) | Human checkpoint kinase, HCDS1, preparations and methods | |
BR9811592A (en) | Cytokinin oxidase | |
BR9803960A (en) | D-sorbitol dehydrogenase gene. | |
DK525384D0 (en) | FACTOR PREPARATION VIII FOR THE TREATMENT OF HAEMOFILI A INHIBITOR PATIENTS AND PROCEDURE FOR THE PREPARATION OF SUCH A PREPARATION | |
ATE121754T1 (en) | VACCINE AGAINST BORDETELLA. | |
LTIP1753A (en) | Dna sequences coding for proteins, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
BR9707785A (en) | Parapoxvirus containing foreign DNA preparation and use in vaccines | |
HUT68379A (en) | Method for modifying the cell, tissue or host tropism of a recombinant microorganism obtained this way and use thereof in medicine and veterinary medicine | |
ATE291088T1 (en) | IMMUNOLOGICALLY ACTIVE PROTEINS OF BORRELIA BURGDORFERI, NUCLEIC ACIDS CODING THEREOF AND THEIR USE IN TEST KITS AND AS VACCINES | |
ES2080060T3 (en) | PROTEINS THAT HAVE ACTIVITY FROM UNION TO INTERFERON-GAMMA. | |
BR9711692A (en) | Regulated steel promoter | |
MY101874A (en) | Vaccine | |
DK0588177T3 (en) | Interferon-alpha / beta-binding protein, preparation thereof and pharmaceutical preparations containing the protein | |
BR9814433A (en) | "beta-lipotropin and its uses" | |
ES2059801T3 (en) | NEW LYMPHOCINES, DNA SEQUENCES CODING FOR THESE LYMPHOCINES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE LYMPHOCINES. | |
BR0016740A (en) | Cryptosporidium sporozoite antigens | |
DK318086A (en) | PREPARATION FOR THE TREATMENT OF HAEMOFILI A INHIBITOR PATIENTS AND PROCEDURE FOR THE PREPARATION OF SUCH PREPARATION | |
ITMI931034A1 (en) | PROCESS FOR THE PREPARATION OF PROTEINS INHIBITING RIBOSOMES | |
BR9810046A (en) | Nucleotide sequence, expression vector, host cell, mammalian sperm protein, recombinant sperm protein, sperm protein 4, 1 and / or 6.7, pharmaceutical composition, and contraceptive vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] |